Department of Surgery, St Michael's Hospital, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
BMJ Open. 2020 Feb 5;10(2):e035411. doi: 10.1136/bmjopen-2019-035411.
Cancer is one of the leading causes of death globally and many jurisdictions have developed population-based cancer screening programmes to reduce the public health burden of disease. However, screening participation remains suboptimal. Social media and other mobile health (mHealth) technologies are increasingly being used for health promotion and behaviour change. This paper reports on the protocol for a systematic review exploring the effect of social media and other mHealth interventions on cancer screening participation and intention.
This protocol is reported in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) checklist. We will include any randomised controlled trials or quasi-experimental studies with a pre/post design conducted in adults ≥18 years of age that report on the effectiveness of a social media or mHealth intervention on screening participation or intention (inclusive of breast, cervical, colorectal, prostate and lung cancer). Interventions will be inclusive of those delivered online or through a computer using an established social media platform or a new purpose-built platform, or those delivered through cellphones or other wireless technologies. Any comparator will be acceptable (control group, alternate intervention or pre/post design). We will search Medline, EMBASE, PsycINFO, Scopus, CINAHL, the Cochrane Central Register of Controlled Trials, and Communication and Mass Media Complete from 1 January 2000 to 31 May 2019. Two independent reviewers will screen titles, abstracts and full-text articles with conflicts resolved through discussion or by a third reviewer, as needed. The two reviewers will also independently complete risk of bias assessments for each included study. We will report on the characteristics of the studies, participants and interventions in descriptive narrative form and report the absolute and relative differences in screening and intention attributable to social media and mobile technology interventions.
As this is a systematic review, ethical approval for conduct of this study is not required. We will pursue publication of study results in a relevant peer-reviewed journal and report our findings according to the PRISMA checklist.
CRD42019139615.
癌症是全球主要死因之一，许多司法管辖区已制定基于人群的癌症筛查计划，以减轻疾病对公共健康的负担。然而，筛查参与率仍然不理想。社交媒体和其他移动健康（mHealth）技术越来越多地用于促进健康和改变行为。本文报告了一项系统评价的方案，该评价旨在探索社交媒体和其他 mHealth 干预措施对癌症筛查参与和意向的影响。
本方案按照系统评价和荟萃分析方案的首选报告项目（PRISMA-P）清单进行报告。我们将纳入任何在 18 岁及以上成年人中进行的、报告社交媒体或 mHealth 干预措施对筛查参与或意向有效性的随机对照试验或准实验研究（包括乳腺癌、宫颈癌、结直肠癌、前列腺癌和肺癌）。干预措施将包括通过在线或使用已建立的社交媒体平台或新的专用平台在计算机上提供的干预措施，或通过手机或其他无线技术提供的干预措施。任何对照措施都是可以接受的（对照组、替代干预措施或前后设计）。我们将从 2000 年 1 月 1 日至 2019 年 5 月 31 日，在 Medline、EMBASE、PsycINFO、Scopus、CINAHL、Cochrane 对照试验中心注册库和传播与大众媒体完整数据库中进行搜索。两名独立审查员将筛选标题、摘要和全文文章，如有冲突，将通过讨论或需要时由第三名审查员解决。两名审查员还将独立完成对每项纳入研究的偏倚风险评估。我们将以描述性叙述形式报告研究的特征、参与者和干预措施，并报告归因于社交媒体和移动技术干预的筛查和意向的绝对和相对差异。
由于这是一项系统评价，因此进行这项研究不需要伦理批准。我们将在相关同行评议期刊上发表研究结果，并按照 PRISMA 清单报告我们的发现。
CRD42019139615。
